Huan-Ping Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Huan-Ping Zhang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Da-Bo Liu
Department of Pediatric Otolaryngology, Shenzhen Hospital, Southern Medical University, Shenzhen, China
1 shared publication Guo-Hao Zhang
Institute of Allergy & Immunology, Shenzhen University School of Medicine, State Key Laboratory of Respiratory Disease Allergy Division at Shenzhen University, Shenzhen, China
1 shared publication- Hanhua Cao
Guangzhou Xinhua university, GuangZhou, GuangDong, China
1 shared publication Jian-Bo Shao
Department of Pediatric Otolaryngology, Shenzhen Hospital, Southern Medical University, Shenzhen, China
1 shared publicationKe Ma
Department of Allergy Medicine, Bethune Hospital Affiliated to Shanxi Medical University, Taiyuan, China
1 shared publicationLi-Hua Mo
Department of Pediatric Otolaryngology, Shenzhen Hospital, Southern Medical University, Shenzhen, China
1 shared publication
Latest Publications
- Open Access
- 17 January 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 5397733
Superoxide Dismutase Prevents SARS‐CoV‐2‐Induced Plasma Cell Apoptosis and Stabilizes Specific Antibody Induction
The infection of coronavirus disease (COVID‐19) seriously threatens human life. It is urgent to generate effective and safe specific antibodies (Abs) against the pathogenic elements of COVID‐19. Mice were immunized with SARS‐CoV‐2 spike protein antigens: S ectodomain‐1 (CoV, in short) mixed in Alum adjuvant for 2 times and boosted with CoV weekly for 6 times. A portion of mice were treated with Maotai liquor (MTL, in short) or/and heat stress (HS) together with CoV boosting. We observed that the anti‐CoV Ab was successfully induced in mice that received the CoV/Alum immunization for 2 times. However, upon boosting with CoV, the CoV Ab production diminished progressively; spleen CoV Ab‐producing plasma cell counts reduced, in which substantial CoV‐specific Ab‐producing plasma cells (sPC) were apoptotic. Apparent oxidative stress signs were observed in sPCs; the results were reproduced by exposing sPCs to CoV in the culture. The presence of MTL or/and HS prevented the CoV‐induced oxidative stress in sPCs and promoted and stabilized the CoV Ab production in mice in re‐exposure to CoV. In summary, CoV/Alum immunization can successfully induce CoV Ab production in mice that declines upon reexposure to CoV. Concurrent administration of MTL/HS stabilizes and promotes the CoV Ab production in mice.
- 17 January 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 5397733
Open AccessSuperoxide Dismutase Prevents SARS‐CoV‐2‐Induced Plasma Cell Apoptosis and Stabilizes Specific Antibody Induction
The infection of coronavirus disease (COVID‐19) seriously threatens human life. It is urgent to generate effective and safe specific antibodies (Abs) against the pathogenic elements of COVID‐19. Mice were immunized with SARS‐CoV‐2 spike protein antigens: S ectodomain‐1 (CoV, in short) mixed in Alum adjuvant for 2 times and boosted with CoV weekly for 6 times. A portion of mice were treated with Maotai liquor (MTL, in short) or/and heat stress (HS) together with CoV boosting. We observed that the anti‐CoV Ab was successfully induced in mice that received the CoV/Alum immunization for 2 times. However, upon boosting with CoV, the CoV Ab production diminished progressively; spleen CoV Ab‐producing plasma cell counts reduced, in which substantial CoV‐specific Ab‐producing plasma cells (sPC) were apoptotic. Apparent oxidative stress signs were observed in sPCs; the results were reproduced by exposing sPCs to CoV in the culture. The presence of MTL or/and HS prevented the CoV‐induced oxidative stress in sPCs and promoted and stabilized the CoV Ab production in mice in re‐exposure to CoV. In summary, CoV/Alum immunization can successfully induce CoV Ab production in mice that declines upon reexposure to CoV. Concurrent administration of MTL/HS stabilizes and promotes the CoV Ab production in mice.